Reprints Archives - Pharma Marketing Network

Home Tags Reprints

Two Pradaxa Post-Marketing Safety Studies Reach Different Conclusions. Boehringer Promotes Only...

Pharma Guy - November 3, 2014

FDA’s “Off-Label Risk Reduction” Approach to Reprint Distribution is “Misguided,” Says...

Pharma Guy - August 15, 2014

WLF to FDA Regarding Distribution of Off-Label Reprints: See You in...

Pharma Guy - June 3, 2014

Distribution of Reprints: Another Example of FDA Flexing Its Enforcement Muscles

Pharma Guy - May 18, 2009

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

The Death of Last-Click: Rethinking Pharma Marketing Measurement

April 10, 2026

Brand vs Medical vs Legal: Who Really Owns the Message in...

April 9, 2026

Why Pharma Campaigns Fail—Even When They’re Fully Compliant

April 9, 2026